A detailed history of Sterling Capital Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 938 shares of MRNA stock, worth $32,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares
938
Previous 1,425 34.18%
Holding current value
$32,473
Previous $95.2 Million 59.05%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$36.85 - $63.93 $17,945 - $31,133
-487 Reduced 34.18%
938 $39 Million
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $90,687 - $178,324
1,425 New
1,425 $95.2 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.